Hisamitsu Pharmaceutical Co Analysis

Hisamitsu Pink Sheet Analysis Notes

About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hisamitsu Pharmaceutical last dividend was issued on the 27th of February 2023. The entity had 2:1 split on the 27th of June 2000. Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.The quote for Hisamitsu Pharmaceutical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Hisamitsu Pharmaceutical Co call the company at 81 3 5293 1720 or check out https://www.hisamitsu.co.jp.

Hisamitsu Pharmaceutical Investment Alerts

Hisamitsu Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hisamitsu Pharmaceutical's market, we take the total number of its shares issued and multiply it by Hisamitsu Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hisamitsu Profitablity

The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Hisamitsu Pharmaceutical Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Hisamitsu Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hisamitsu shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Hisamitsu Pharmaceutical. By using and applying Hisamitsu Pink Sheet analysis, traders can create a robust methodology for identifying Hisamitsu entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

If you are still planning to invest in Hisamitsu Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hisamitsu Pharmaceutical's history and understand the potential risks before investing.